Search Results

AZD8055 50mg 50mg  | Purity Not Available

Adooq Bioscience

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.

More Information Supplier Page

AZD8055 25mg 25mg  | Purity Not Available

Adooq Bioscience

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.

More Information Supplier Page

AZD8055 100mg 100mg  | Purity Not Available

Adooq Bioscience

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.

More Information Supplier Page

AZD1152-HQPA 5mg 5mg  | Purity Not Available

Adooq Bioscience

AZD 1152-HQPA is a highly potent and selective inhibitor of Aurora B, with Ki values to be 0.36 (Aurora B) and 1369 nM (Aurora A) respectively and has a high specificity versus a panel of 50 other kinases.

More Information Supplier Page

AZD1152-HQPA (Barasertib) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

AZD 1152-HQPA is a highly potent and selective inhibitor of Aurora B, with Ki values to be 0.36 (Aurora B) and 1369 nM (Aurora A) respectively and has a high specificity versus a panel of 50 other kinases.

More Information Supplier Page

AZD1152-HQPA 100mg 100mg  | Purity Not Available

Adooq Bioscience

AZD 1152-HQPA is a highly potent and selective inhibitor of Aurora B, with Ki values to be 0.36 (Aurora B) and 1369 nM (Aurora A) respectively and has a high specificity versus a panel of 50 other kinases.

More Information Supplier Page

AZD1152-HQPA 10mg 10mg  | Purity Not Available

Adooq Bioscience

AZD 1152-HQPA is a highly potent and selective inhibitor of Aurora B, with Ki values to be 0.36 (Aurora B) and 1369 nM (Aurora A) respectively and has a high specificity versus a panel of 50 other kinases.

More Information Supplier Page

Saracatinib 25mg 25mg  | Purity Not Available

Adooq Bioscience

Saracatinib (AZD0530) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively.

More Information Supplier Page

Saracatinib 200mg 200mg  | Purity Not Available

Adooq Bioscience

Saracatinib (AZD0530) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively.

More Information Supplier Page